These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15319839)

  • 1. [Xenon - noble gas with organprotective properties].
    Preckel B; Weber N; Schlack W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Aug; 39(8):456-62. PubMed ID: 15319839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on inhalational anaesthetics.
    De Hert SG; Preckel B; Schlack WS
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):491-5. PubMed ID: 19369864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalational anaesthetics and cardioprotection.
    Weber NC; Schlack W
    Handb Exp Pharmacol; 2008; (182):187-207. PubMed ID: 18175092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial protection by volatile anesthetics].
    Preckel B; Müllenheim J; Schlack W
    Anaesthesiol Reanim; 2002; 27(5):116-23. PubMed ID: 12451935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon.
    Abraini JH; David HN; Lemaire M
    Ann N Y Acad Sci; 2005 Aug; 1053():289-300. PubMed ID: 16179534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anaesthetics?
    Minguet G; Joris J; Lamy M
    Eur J Anaesthesiol; 2007 Sep; 24(9):733-45. PubMed ID: 17555610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sevoflurane post-conditioning protects against myocardial reperfusion injury by activation of phosphatidylinositol-3-kinase signal transduction.
    Li H; Wang JK; Zeng YM; Yang CX; Chen HT; Wen XJ; Shui CL; Liang H
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1043-51. PubMed ID: 18505453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Xenon anaesthesia--clinical characteristics, benefits and disadvantages and fields of application].
    Höcker J; Grünewald M; Bein B
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2012 Jun; 47(6):374-80. PubMed ID: 22744851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models.
    Rajakumaraswamy N; Ma D; Hossain M; Sanders RD; Franks NP; Maze M
    Neurosci Lett; 2006 Dec; 409(2):128-33. PubMed ID: 17052852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upstream signaling of protein kinase C-epsilon in xenon-induced pharmacological preconditioning. Implication of mitochondrial adenosine triphosphate dependent potassium channels and phosphatidylinositol-dependent kinase-1.
    Weber NC; Toma O; Damla H; Wolter JI; Schlack W; Preckel B
    Eur J Pharmacol; 2006 Jun; 539(1-2):1-9. PubMed ID: 16716295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenon as an anesthetic agent.
    Jordan BD; Wright EL
    AANA J; 2010 Oct; 78(5):387-92. PubMed ID: 21067086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardioprotection by anesthetics].
    Hara T
    Masui; 2006 May; 55(5):552-9. PubMed ID: 16715909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The concept of anaesthetic-induced cardioprotection: mechanisms of action.
    Weber NC; Schlack W
    Best Pract Res Clin Anaesthesiol; 2005 Sep; 19(3):429-43. PubMed ID: 16013692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoflurane and other commonly used anaesthetics do not protect the isolated buffer perfused mouse heart from ischemia-reperfusion injury.
    Galagudza M; Vaage J; Valen G
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):315-9. PubMed ID: 16620294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brain and spinal cord preconditioning for the protection against ischemic injury].
    Matsumoto M; Ishida K; Sakabe T
    Masui; 2007 Mar; 56(3):285-97. PubMed ID: 17366916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.
    Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C
    Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How xenon works: neuro and cardioprotection mechanisms].
    Morais R; Andrade L; Lourenço A; Tavares J
    Acta Med Port; 2014; 27(2):259-65. PubMed ID: 24813496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection.
    Shimizu M; Tropak M; Diaz RJ; Suto F; Surendra H; Kuzmin E; Li J; Gross G; Wilson GJ; Callahan J; Redington AN
    Clin Sci (Lond); 2009 Aug; 117(5):191-200. PubMed ID: 19175358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of xenon- and isoflurane-induced preconditioning - a potential link to the cytoskeleton via the MAPKAPK-2/HSP27 pathway.
    Weber NC; Toma O; Wolter JI; Wirthle NM; Schlack W; Preckel B
    Br J Pharmacol; 2005 Oct; 146(3):445-55. PubMed ID: 16086037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
    Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
    Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.